Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins

Journal of Theoretical Biology

Volumn 342, Issue , 2014, Pages 70-82

  Zhang, Jiapu ^a   Zhang, Yuanli ^b  

^a UNIVERSITY OF BALLARAT   (Australia)

^b TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

Molecular dynamics study; NMR and X ray structures; Prion diseases; Rabbit prion proteins; Wild type and mutants

Indexed keywords

ARGININE; ASPARAGINE; ISOLEUCINE; MUTANT PROTEIN; PRION PROTEIN; VALINE;

EXPERIMENTAL STUDY; MOLECULAR ANALYSIS; NUCLEAR MAGNETIC RESONANCE; PH; PROTEIN; SMALL MAMMAL; X-RAY;

ALPHA HELIX; ARTICLE; BETA SHEET; MOLECULAR DYNAMICS; MUTANT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN UNFOLDING; RABBIT; WILD TYPE; X RAY ANALYSIS;

BOS; BOVINAE; CAPRA HIRCUS; CERVIDAE; MAMMALIA; ORYCTOLAGUS CUNICULUS; OVIS ARIES;

MOLECULAR DYNAMICS STUDY; NMR AND X-RAY STRUCTURES; PRION DISEASES; RABBIT PRION PROTEINS; WILD-TYPE AND MUTANTS;

ANIMALS; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR DYNAMICS SIMULATION; PRIONS; PROTEIN STRUCTURE, SECONDARY; RABBITS; TEMPERATURE; X-RAYS;

EID: 84888405629     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2013.10.005     Document Type: Article

References (144)

1. Barlow R.M., Rennie J.C. The fate of ME7 scrapie infection in rats, guinea-pigs and rabbits. Res. Vet. Sci. 1976, 21:110-111.
2. Baron H., Baron-Van Evercooren A., Brucher J.M. Antiserum to scrapie-associated fibril protein reacts with amyloid plaques in familial transmissible dementia. J. Neuropathol. Exp. Neurol. 1988, 47(2):158-165.
3. Barry R.A., Kent S.B., McKinley M.P., Meyer R.K., DeArmond S.J., Hood L.E., Prusiner S.B. Scrapie and cellular prion proteins share polypeptide epitopes. J. Infect. Dis. 1986, 153(5):848-854.
4. Barry R.A., McKinley M.P., Bendheim P.E., Lewis G.K., DeArmond S.J., Prusiner S.B. Antibodies to the scrapie protein decorate prion rods. J. Immunol. 1985, 135(1):603-613.
5. Barry R.A., Vincent M.T., Kent S.B., Hood L.E., Prusiner S.B. Characterization of prion proteins with monospecific antisera to synthetic peptides. J. Immunol. 1988, 140(4):1188-1193.
6. Bastian F.O., Sanders D.E., Forbes W.A., Hagius S.D., Walker J.V., Henk W.G., Enright F.M., Elzer P.H. Spiroplasma spp. from transmissible spongiform encephalopathy brains or ticks induce spongiform encephalopathy in ruminants. J. Med. Microbiol. 2007, 56(Pt 9):1235-1242.
7. Bencsik A., Lezmi S., Hunsmann G., Baron T. Close vicinity of PrP expressing cells (FDC) with noradrenergic fibers in healthy sheep spleen. Dev. Immunol. 2001, 8(3-4):235-241.
8. Bendheim P.E., Barry R.A., DeArmond S.J., Stites D.P., Prusiner S.B. Antibodies to a scrapie prion protein. Nature 1984, 310(5976):418-421.
9. Bett C., Fernández-Borges N., Kurt T.D., Lucero M., Nilsson K.P., Castilla J., Sigurdson C.J. Structure of the β2--α2 loop and interspecies prion transmission. FASEB J. 2012, 26(7):2868-2876.
10. Biswas S., Langeveld J.P., Tipper D., Lu S. Intracellular accumulation of a 46 kDa species of mouse prion protein as a result of loss of glycosylation in cultured mammalian cells. Biochem. Biophys. Res. Commun. 2006, 349(1):153-161.
11. Bitel C.L., Feng Y., Souayah N., Frederikse P.H. Increased expression and local accumulation of the prion protein, Alzheimer A peptides, superoxide dismutase 1, and nitric oxide synthases 1 & 2 in muscle in a rabbit model of diabetes. BMC Physiol. 2010, 10:18. 10.1186/1472-6793-10-18.
12. PrPC to PrP conversion process. Biochemistry 2011, 50(7):1162-1173.
13. Bockman J.M., Prusiner S.B., Tateishi J., Kingsbury D.T. Immunoblotting of Creutzfeldt-Jakob disease prion proteins. host species-specific epitopes. Ann. Neurol. 1987, 21(6):589-595.
14. Bode L., Pocchiari M., Gelderblom H., Diringer H. Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease. J. Gen. Virol. 1985, 66(Pt 11):2471-2478.
15. Brun A., Castilla J., Ramírez M.A., Prager K., Parra B., Salguero F.J., Shiveral D., Sánchez C., Sánchez-Vizcaíno J.M., Douglas A., Torres J.M. Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11. Neurosci. Res. 2004, 48(1):75-83.
16. Caughey B., Race R., Vogel M., Buchmeier M., Chesebro B. In vitro expression of cloned PrP cDNA derived from scrapie-infected mouse brain. lack of transmission of scrapie infectivity. Ciba Found. Symp. 1988, 135:197-208.
17. Chianini F., Fernndez-Borges N., Vidal E., Gibbard L. Rabbits are not resistant to prion infection. Proc. Natl. Acad. Sci. USA 2012, 109(13):5080-5085.
18. Cho H.J. Antibody to scrapie-associated fibril protein identifies a cellular antigen. J. Gen. Virol. 1986, 67(Pt 2):243-253.
19. Chou K.C. The biological functions of low-frequency phonons. 6. A possible dynamic mechanism of allosteric transition in antibody molecules. Biopolymers 1987, 26:285-295.
20. Chou K.C. Review. low-frequency collective motion in biomacromolecules and its biological functions. Biophys. Chem. 1988, 30:3-48.
21. Chou K.C. Low-frequency resonance and cooperativity of hemoglobin. Trends Biochem. Sci. 1989, 14:212-213.
22. Chou K.C., Lin W.Z., Xiao X. Wenxiang. a web-server for drawing Wenxiang diagrams. Nat. Sci. 2011, 3:862-865.
23. Chou K.C., Mao B. Collective motion in DNA and its role in drug intercalation. Biopolymers 1988, 27:1795-1815.
24. Chou K.C., Zhang C.T., Maggiora G.M. Solitary wave dynamics as a mechanism for explaining the internal motion during microtubule growth. Biopolymers 1994, 34:143-153.
25. Chou K.C., Zhang C.T., Maggiora G.M. Disposition of amphiphilic helices in heteropolar environments. Proteins. Struct. Funct. Genet. 1997, 28:99-108.
26. Christen B., Damberger F.F., Pérez D.R., Hornemann S., Wüthrich K. Structural plasticity of the cellular prion protein and implications in health and disease. Proc. Natl. Acad. Sci. USA 2013, 110(21):8549-8554.
27. Christen B., Hornemann S., Damberger F.F., Wüthrich K. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the β2-α2 loop is modulated by long-range sequence effects. J. Mol. Biol. 2009, 389(5):833-845.
28. Christen B., Hornemann S., Damberger F.F., Wüthrich K. Prion protein mPrP [F175A](121-231). structure and stability in solution. J. Mol. Biol. 2012, 423(4):496-502.
29. Christen B., Pérez D.R., Hornemann S., Wüthrich K. NMR structure of the bank vole prion protein at 20°C contains a structured loop of residues 165-171. J. Mol. Biol. 2008, 383(2):306-312.
30. Cong X., Bongarzone S., Giachin G., Rossetti G., Carloni P., Legname G. Dominantnegative effects in prion diseases. insights from molecular dynamics simulations on mouse prion protein chimeras. J. Biomol. Struct. Dyn. 2013, 31(8):829-840.
31. Courageot M.P., Daude N., Nonno R., Paquet S., Di Bari M.A., Le Dur A., Chapuis J., Hill A.F., Agrimi U., Laude H., Vilette D. A cell line infectible by prion strains from different species. J. Gen. Virol. 2008, 89(1):341-347.
32. Damberger F.F., Christen B., Pérez D.R., Hornemann S., Wüthrich K. Cellular prion protein conformation and function. Proc. Natl. Acad. Sci. USA 2011, 108(42):17308-17313.
33. Di Martino A., Bigon E., Corona G., Callegaro L. Production and characterization of antibodies to mouse scrapie-amyloid protein elicited by non-carrier linked synthetic peptide immunogens. J. Mol. Recognit. 1991, 4(2-3):85-91.
34. Dong C.F., Wang X.F., An R., Chen J.M., Shan B., Han L., Lei Y.J., Han J., Dong X.P. [Interaction analysis between various PrP fusion proteins and the tubulin in vitro]. Bing Du Xue Bao 2007, 23(1):28-32.
35. Dupiereux I., Zorzi W., Rachidi W., Zorzi D., Pierard O., Lhereux B., Heinen E., Elmoualij B. Study on the toxic mechanism of prion protein peptide 106-126 in neuronal and non neuronal cells. J. Neurosci. Res. 2006, 84(3):637-646.
36. Farquhar C.F., Somerville R.A., Ritchie L.A. Post-mortem immunodiagnosis of scrapie and bovine spongiform encephalopathy. J. Virol. Methods 1989, 24(1-2):215-221.
37. Fernández-Borges N., Chianini F., Eraña H., Vidal E., Eaton S.L., Pintado B., Finlayson J., Dagleish M.P., Castilla J. Naturally prion resistant mammals. a utopia?. Prion 2012, 6(5):425-429.
38. Fernandez-Funez P., Casas-Tinto S., Zhang Y., Gomez-Velazquez M., Morales-Garza M.A., Cepeda-Nieto A.C., Castilla J., Soto C., Rincon-Limas D.E. In vivo generation of neurotoxic prion protein. role for hsp70 in accumulation of misfolded isoforms. PLoS Genet. 2009, 5(6):e1000507.
39. Fernandez-Funez P., Zhang Y., Casas-Tinto S., Xiao X., Zou W.Q., Rincon-Limas D.E. Sequence-dependent prion protein misfolding and neurotoxicity. J. Biol. Chem. 2010, 285(47):36897-36908.
40. Fernandez-Funez P., Zhang Y., Sanchez-Garcia J., Jensen K., Zou W.Q., Rincon-Limas D.E. Pulling rabbits to reveal the secrets of the prion protein. Commun. Integr. Biol. 2011, 4(3):262-266.
41. Friedman-Levi Y., Mizrahi M., Frid K., Binyamin O., Gabizon R. PrPST, a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease. PLoS One 2013, 8(7):e69583.
42. Gabizon R., McKinley M.P., Groth D., Prusiner S.B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc. Natl. Acad. Sci. USA 1988, 85(18):6617-6621.
43. Gabizon R., McKinley M.P., Groth D., Westaway D., DeArmond S.J., Carlson G.A., Prusiner S.B. Immunoaffinity purification and neutralization of scrapie prions. Prog. Clin. Biol. Res. 1989, 317:583-600.
44. Gao C., Lei Y.J., Han J., Shi Q., Chen L., Guo Y., Gao Y.J., Chen J.M., Jiang H.Y., Zhou W., Dong X.P. Recombinant neural protein PrP can bind with both recombinant and native apolipoprotein E in vitro. Acta Biochim. Biophys. Sin. (Shanghai) 2006, 38(9):593-601.
45. Garssen G.J., VanKeulen L.J., Farquhar C.F., Smits M.A., Jacobs J.G., Bossers A., Meloen R.H., Langeveld J.P. Applicability of three anti-PrP peptide sera including staining of tonsils and brainstem of sheep with scrapie. Microsc. Res. Tech. 2000, 50(1):32-39.
46. Gerber R., Tahiri-Alaoui A., Hore P.J., James W. Conformational pH dependence of intermediate states during oligomerization of the human prion protein. Protein Sci. 2008, 17(3):537-544.
47. Gilch S., Wopfner F., Renner-Müller I., Kremmer E., Bauer C., Wolf E., Brem G., Groschup M.H., Schätzl H.M. Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J. Biol. Chem. 2003, 278(20):18524-18531.
48. Golanska E., Hulas-Bigoszewska K., Sikorska B., Liberski P.P. [Analyses of 14-3-3 protein in the cerebrospinal fluid in Creutzfeldt-Jakob disease. Preliminary report]. Neurol. Neurochir. Pol. 2005, 39(5):358-365.
49. Gossert A.D., Bonjour S., Lysek D.A., Fiorito F., Wüthrich K. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc. Natl. Acad. Sci. USA 2005, 102(3):646-650.
50. Garrec J., Tavernelli I., Rothlisberger U. Two misfolding routes for the prion protein around pH 4.5. PLoS Comput. Biol. 2013, 9(5):e1003057.
51. Groschup M.H., Harmeyer S., Pfaff E. Antigenic features of prion proteins of sheep and of other mammalian species. J. Immunol. Methods 1997, 207(1):89-101.
52. Groschup M.H., Langeveld J., Pfaff E. The major species specific epitope in prion proteins of ruminants. Arch. Virol. 1994, 136(3-4):423-431.
53. Groschup M.H., Pfaff E. Studies on a species-specific epitope in murine, ovine and bovine prion protein. J. Gen. Virol. 1993, 74(7):1451-1456.
54. Guiroy D.C., Marsh R.F., Yanagihara R., Gajdusek D.C. Immunolocalization of scrapie amyloid in non-congophilic, non-birefringent deposits in golden Syrian hamsters with experimental transmissible mink encephalopathy. Neurosci. Lett. 1993, 155(1):112-115.
55. Handisurya A., Gilch S., Winter D., Shafti-Keramat S., Maurer D., Schätzl H.M., Kirnbauer R. Vaccination with prion peptide-displaying papillomavirus-like particles induces autoantibodies to normal prion protein that interfere with pathologic prion protein production in infected cells. FEBS J. 2007, 274(7):1747-1758.
56. Hanoux V., Wijkhuisen A., Alexandrenne C., Créminon C., Boquet D., Couraud J.Y. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein. Mol. Immunol. 2009, 46(6):1076-1083.
57. Hashimoto K., Mannen T., Nukina N. Immunohistochemical study of kuru plaques using antibodies against synthetic prion protein peptides. Acta. Neuropathol. 1992, 83(6):613-617.
58. Hay B., Prusiner S.B., Lingappa V.R. Evidence for a secretory form of the cellular prion protein. Biochemistry 1987, 26(25):8110-8115.
59. Huang P., Lian F., Wen Y., Guo C., Lin D. Prion protein oligomer and its neurotoxicity. Acta. Biochim. Biophys. Sin. (Shanghai) 2013, 45(6):442-451.
60. Ikegami Y., Ito M., Isomura H., Momotani E., Sasaki K., Muramatsu Y., Ishiguro N., Shinagawa M. Pre-clinical and clinical diagnosis of scrapie by detection of PrP protein in tissues of sheep. Vet. Rec. 1991, 128(12):271-275.
61. Ishiguro N., Inoshima Y., Sassa Y., Takahashi T. Molecular characterization of chicken prion proteins by C-terminal-specific monoclonal antibodies. Vet. Immunol. Immunopathol. 2009, 128(4):402-406.
62. Ishikawa T., Kuwata K. Interaction analysis of the native structure of prion protein with quantum chemical calculations. J. Chem. Theor. Comput. 2010, 6:538-547.
63. Jackman R., Schmerr M.J. Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence. Electrophoresis 2003, 24(5):892-896.
64. Julien O., Chatterjee S., Bjorndahl T.C., Sweeting B., Acharya S., Semenchenko V., Chakrabartty A., Pai E.F., Wishart D.S., Sykes B.D., Cashman N.R. Relative and regional stabilities of the hamster, mouse, rabbit, and bovine prion proteins toward urea unfolding assessed by nuclear magnetic resonance and circular dichroism spectroscopies. Biochemistry 2011, 50(35):7536-7545.
65. Kabsch W., Sander C. Dictionary of protein secondary structure. pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983, 22:2577-2637.
66. Kascsak R.J., Rubenstein R., Merz P.A., Carp R.I., Robakis N.K., Wisniewski H.M., Diringer H. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 1986, 59(3):676-683.
67. Kascsak R.J., Rubenstein R., Merz P.A., Tonna-DeMasi M., Fersko R., Carp R.I., Wisniewski H.M., Diringer H. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 1987, 61(12):3688-3693.
68. Kelker M., Kim C., Chueh P.J., Guimont R., Morré D.M., Morré D.J. Cancer isoform of a tumor-associated cell surface NADH oxidase (tNOX) has properties of a prion. Biochemistry 2001, 40(25):7351-7354.
69. Khan M.Q., Sweeting B., Mulligan V.K., Arslan P.E., Cashman N.R., Pai E.F., Chakrabartty A. Prion disease susceptibility is affected by β-structure folding propensity and local side-chain interactions in PrP. Proc. Natl. Acad. Sci. USA 2010, 107(46):19808-19813.
70. Kim H.J., Tark D.S., Lee Y.H., Kim M.J., Lee W.Y., Cho I.S., Sohn H.J., Yokoyama T. Establishment of a cell line persistently infected with chronic wasting disease prions. J. Vet. Med. Sci. 2012, 74(10):1377-1380.
71. Kirby L., Agarwal S., Graham J.F., Goldmann W., Gill A.C. Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants. Biochemistry 2010, 49(7):1448-1459.
72. Kirkwood J.K., Wells G.A., Cunningham A.A., Jackson S.I., Scott A.C., Dawson M., Wilesmith J.W. Scrapie-like encephalopathy in a greater kudu (Tragelaphus strepsiceros) which had not been fed ruminant-derived protein. Vet. Rec. 1992, 130(17):365-367.
73. Kitamoto T., Tateishi J., Sawa H., Doh-Ura K. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques. Lab. Invest. 1989, 60(4):507-512.
74. Kocisko D.A., Caughey B. Searching for anti-prion compounds. cell-based high-throughput in vitro assays and animal testing strategies. Methods Enzymol. 2006, 412:223-234.
75. Komar A.A., Lesnik T., Cullin C., Guillemet E., Ehrlich R., Reiss C. Differential resistance to proteinase K digestion of the yeast prion-like (Ure2p) protein synthesized in vitro in wheat germ extract and rabbit reticulocyte lysate cell-free translation systems. FEBS Lett. 1997, 415(1):6-10.
76. Korth C., Stierli B., Streit P., Moser M., Schaller O., Fischer R., Schulz-Schaeffer W., Kretzschmar H., Raeber A., Braun U., Ehrensperger F., Hornemann S., Glockshuber R., Riek R., Billeter M., Wthrich K., Oesch B. Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature 1997, 390(55):74-77.
77. Laude H., Vilette D., LeDur A., Archer F., Soulier S., Besnard N., Essalmani R., Vilotte J.L. New in vivo and ex vivo models for the experimental study of sheep scrapie: development and perspectives. C. R. Biol. 2002, 325(1):49-57.
78. Lawson V.A., Vella L.J., Stewart J.D., Sharples R.A., Klemm H., Machalek D.M., Masters C.L., Cappai R., Collins S.J., Hill A.F. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. Int. J. Biochem. Cell. Biol. 2008, 40(12):2793-2801.
79. 15N resonance assignments of rabbit prion protein 91-228. J. Biomol. NMR 2007, 38:181.
80. Li Y.M., Tian B., Zhang B.Y., Dong X.P. [Diagnosis of bovine spongiform encephalopathy and scrapie by Western blot]. Sheng Wu Gong Cheng Xue Bao 2001, 17(5):494-497.
81. Loftus B., Rogers M. Characterization of a prion protein (PrP) gene from rabbit; a species with apparent resistance to infection by prions. Gene 1997, 184(2):215-219.
82. Lopez C.D., Yost C.S., Prusiner S.B., Myers R.M., Lingappa V.R. Unusual topogenic sequence directs prion protein biogenesis. Science 1990, 248(4952):226-229.
83. Lührs T., Riek R., Güntert P., Wüthrich K. NMR structure of the human doppel protein. J. Mol. Biol. 2003, 326(5):1549-1557.
84. Ma Q., Fan J.B., Zhou Z., Zhou B.R., Meng S.R., Hu J.Y., Chen J., Liang Y. The contrasting effect of macromolecular crowding on amyloid fibril formation. PLoS One 2012, 7(4):e36288.
85. Madec J.Y., Vanier A., Dorier A., Bernillon J., Belli P., Baron T. Biochemical properties of protease resistant prion protein PrPSc in natural sheep scrapie. Arch. Virol. 1997, 142(8):1603-1612.
86. Mays C.E., Yeom J., Kang H.E., Bian J., Khaychuk V., Kim Y., Bartz J.C., Telling G.C., Ryou C. In vitro amplification of misfolded prion protein using lysate of cultured cells. PLoS One 2011, 6(3):e18047.
87. Meli M., Gasset M., Colombo G. Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target. PLoS One 2011, 6(4):e19093.
88. Merz P.A., Kascsak R.J., Rubenstein R., Carp R.I., Wisniewski H.M. Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J. Virol. 1987, 61(1):42-49.
89. Miller J.M., Jenny A.L., Taylor W.D., Marsh R.F., Rubenstein R., Race R.E. Immunohistochemical detection of prion protein in sheep with scrapie. J. Vet. Diagn. Invest. 1993, 5(3):309-316.
90. Nisbet R.M., Harrison C.F., Lawson V.A., Masters C.L., Cappai R., Hill A.F. Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection. insight from the resistance of rabbits to prion disease. J. Virol. 2010, 84(13):6678-6686.
91. Oboznaya M.B., Gilch S., Titova M.A., Koroev D.O., Volkova T.D., Volpina O.M., Schätzl H.M. Antibodies to a nonconjugated prion protein peptide 95-123 interfere with PrPSc propagation in prion-infected cells. Cell Mol. Neurobiol. 2007, 27(3):271-284.
92. Onodera T., Ikeda T., Muramatsu Y., Shinagawa M. Isolation of scrapie agent from the placenta of sheep with natural scrapie in Japan. Microbiol. Immunol. 1993, 37(4):311-316.
93. Pérez D.R., Damberger F.F., Wüthrich K. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J. Mol. Biol. 2010, 400(2):121-128.
94. Polymenidou M., Trusheim H., Stallmach L., Moos R., Julius C., Miele G., Lenz-Bauer C., Aguzzi A. Canine MDCK cell lines are refractory to infection with human and mouse prions. Vaccine 2008, 26(21):2601-2614.
95. Riek R., Hornemann S., Wider G., Billeter M., Glockshuber R., Wüthrich K. NMR structure of the mouse prion protein domain PrP(121-231). Nature 1996, 382(6587):180-182.
96. Robakis N.K., Sawh P.R., Wolfe G.C., Rubenstein R., Carp R.I., Innis M.A. Isolation of a cDNA clone encoding the leader peptide of prion protein and expression of the homologous gene in various tissues. Proc. Natl. Acad. Sci. USA 1986, 83(17):6377-6381.
97. Roberts G.W., Lofthouse R., Allsop D., Landon M., Kidd M., Prusiner S.B., Crow T.J. CNS amyloid proteins in neurodegenerative diseases. Neurology 1988, 38(10):1534-1540.
98. Rossetti G., Giachin G., Legname G., Carloni P. Structural facets of disease-linked human prion protein mutants. a molecular dynamic study. Proteins 2010, 78(16):3270-3280.
99. Sachsamanoglou M., Paspaltsis I., Petrakis S., Verghese-Nikolakaki S., Panagiotidis C.H., Voigtlander T., Budka H., Langeveld J.P., Sklaviadis T. Antigenic profile of human recombinant PrP. generation and characterization of a versatile polyclonal antiserum. J. Neuroimmunol. 2004, 146(1-2):22-32.
100. Sakudo A., Nakamura I., Tsuji S., Ikuta K. GPI-anchorless human prion protein is secreted and glycosylated but lacks superoxide dismutase activity. Int. J. Mol. Med. 2008, 21(2):217-222.
101. Schmerr M.J., Goodwin K.R., Cutlip R.C. Capillary electrophoresis of the scrapie prion protein from sheep brain. J. Chromatogr. A 1994, 680(2):447-453.
102. Senator A., Rachidi W., Lehmann S., Favier A., Benboubetra M. Prion protein protects against DNA damage induced by paraquat in cultured cells. Free Radic. Biol. Med. 2004, 37(8):1224-1230.
103. Shin W., Lee B., Hong S., Ryou C., Kwon M. Cloning and expression of a prion protein (PrP) gene from Korean bovine (Bos taurus coreanae) and production of rabbit anti-bovine PrP antibody. Biotechnol. Lett. 2008, 30(10):1705-1711.
104. Shinagawa M., Munekata E., Doi S., Takahashi K., Goto H., Sato G. Immunoreactivity of a synthetic pentadecapeptide corresponding to the N-terminal region of the scrapie prion protein. J. Gen. Virol. 1986, 67(Pt 8):1745-1750.
105. Sigurdson C.J., Joshi-Barr S., Bett C., Winson O., Manco G., Schwarz P., Rülicke T., Nilsson K.P., Margalith I., Raeber A., Peretz D., Hornemann S., Wüthrich K., Aguzzi A. Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein. J. Neurosci. 2011, 31(39):13840-13847.
106. Sigurdson C.J., Nilsson K.P., Hornemann S., Heikenwalder M., Manco G., Schwarz P., Ott D., Rülicke T., Liberski P.P., Julius C., Falsig J., Stitz L., Wüthrich K., Aguzzi A. De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc. Natl. Acad. Sci. USA 2009, 106(1):304-309.
107. Sigurdson C.J., Nilsson K.P., Hornemann S., Manco G., Fernández-Borges N., Schwarz P., Castilla J., Wüthrich K., Aguzzi A. A molecular switch controls interspecies prion disease transmission in mice. J. Clin. Invest. 2010, 120(7):2590-2599.
108. Stanker L.H., Scotcher M.C., Lin A., McGarvey J., Prusiner S.B., Hnasko R. Novel epitopes identified by anti-PrP monoclonal antibodies produced following immunization of Prnp0/0 Balb/cJ mice with purified scrapie prions. Hybridoma (Larchmt) 2012, 31(5):314-324.
109. Sweeting, B., Brown, E., Chakrabartty, A., Pai, E.F., 2009. The Structure of Rabbit PrPC: Clues into Species Barrier and Prion Disease. Canadian Light Source 2009 Activity Report 28, pp. 72.
110. Sweeting B., Brown E., Khan M.Q., Chakrabartty A., Pai E.F. N-terminal helix-cap in α-helix 2 modulates β-state misfolding in rabbit and hamster prion proteins. PLoS One 2013, 8(5):e63047.
111. Takahashi K., Shinagawa M., Doi S., Sasaki S., Goto H., Sato G. Purification of scrapie agent from infected animal brains and raising of antibodies to the purified fraction. Microbiol. Immunol. 1986, 30(2):123-131.
112. Takahashi H., Takahashi R.H., Hasegawa H., Horiuchi M., Shinagawa M., Yokoyama T., Kimura K., Haritani M., Kurata T., Nagashima K. Characterization of antibodies raised against bovine-PrP-peptides. J. Neurovirol. 1999, 5(3):300-307.
113. Takekida K., Kikuchi Y., Yamazaki T., Kakeya T., Takatori K., Tanamoto K., Sawada J., Tanimura A. [Study on the detection of prion protein in food products by a competitive enzyme-linked immunosorbent assay]. Shokuhin. Eiseigaku. Zasshi. 2002, 43(3):173-177.
114. Timmes A.G., Moore R.A., Fischer E.R., Priola S.A. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One 2013, 8(7):e71081.
115. Tang H., Fu Y., Cui Y., He Y., Zeng X., Ploplis V.A., Castellino F.J., Luo Y. Fibrinogen has chaperone-like activity. Biochem. Biophys. Res. Commun. 2009, 378(3):662-667.
116. Verdier, J.M., 2012. Prions and Prion Diseases: New Developments. NOVA Science Publishers, New York, ISBN 978-1-62100-027-3, Preface, pp. vii-ix.
117. Vidal E., Fernáñdez-Borges N., Pintado B., Ordónez M., Márquez M., Fondevila D., Torres J.M., Pumarola M., Castilla J. Bovine spongiform encephalopathy induces misfolding of alleged prion-resistant species cellular prion protein without altering its pathobiological features. J. Neurosci. 2013, 33(18):7778-7786.
118. Vilette D., Andreoletti O., Archer F., Madelaine M.F., Vilotte J.L., Lehmann S., Laude H. Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein. Proc. Natl. Acad. Sci. USA 2001, 98:4055-4059.
119. Vol'pina O.M., Zhmak M.N., Obozhaia M.B., Titova M.A., Koroev D.O., Volkova T.D., Egorov A.A., Ivanov V.T. [Antibodies against synthetic fragments of the prion protein for the diagnosis of bovine spongiform encephalopathy]. Bioorg. Khim. 2001, 27(5):352-358.
120. Vorberg I., Martin H.G., Eberhard P., Suzette A.P. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J. Virol. 2003, 77:2003-2009.
121. Wade W.F., Dees C., German T.L., Marsh R.F. Immunochemical characterization of proteins from scrapie-infected hamster brain, using immunoblot analysis. Am. J. Vet. Res. 1987, 48(7):1077-1081.
122. Wang, H., Yang, L., Kouadir, M., Tan, R., Wu, W., Zou, H., Wang, J., Khan, S.H., Li, D., Zhou, X., Yin, X., Wang, Y., Zhao, D., 2013. Expression and distribution of laminin receptor precursor/laminin receptor in rabbit tissues. J. Mol. Neurosci. 2013 May 30. [Epub ahead of print].
123. Wang Y., Zhao S., Bai L., Fan J., Liu E. Expression systems and species used for transgenic animal bioreactors. Biomed. Res. Int. 2013, 2013:580463. 10.1155/2013/580463.
124. Wen Y., Li J., Xiong M., Peng Y., Yao W., Hong J., Lin D. Solution structure and dynamics of the I214V mutant of the rabbit prion protein. PLoS One 2010, 5(10):e13273.
125. Wen Y., Li J., Yao W., Xiong M., Hong J., Peng Y., Xiao G., Lin D. Unique structural characteristics of the rabbit prion protein. J. Biol. Chem. 2010, 285(41):31682-31693.
126. Wiley C.A., Burrola P.G., Buchmeier M.J., Wooddell M.K., Barry R.A., Prusiner S.B., Lampert P.W. Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab. Invest. 1987, 57(6):646-656.
127. Xi Y.G., Cardone F., Pocchiari M. Detection of proteinase-resistant protein (PrP) in small brain tissue samples from Creutzfeldt-Jakob disease patients. J. Neurol. Sci. 1994, 124(2):171-173.
128. Xiao X.L., Han J., Zhang L., Chen L., Zhang J., Chen X.L., Zhou W., Jiang H.Y., Zhang B.Y., Liu Y., Dong X.P. Protein expression of human neuron-specific enolase and its antiserum preparation. Nan Fang Yi Ke Da Xue Xue Bao 2006, 26(11):1543-1547.
129. Yokoyama T., Itohara S., Yuasa N. Detection of species specific epitopes of mouse and hamster prion proteins (PrPs) by anti-peptide antibodies. Arch. Virol. 1996, 141(3-4):763-769.
130. Yokoyama T., Kimura K., Tagawa Y., Yuasa N. Preparation and characterization of antibodies against mouse prion protein (PrP) peptides. Clin. Diagn. Lab. Immunol. 1995, 2(2):172-176.
131. Yost C.S., Lopez C.D., Prusiner S.B., Myers R.M., Lingappa V.R. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 1990, 343(6259):669-672.
132. Zahn R., Liu A., Lührs T., Riek R., von Schroetter C., López García F., Billeter M., Calzolai L., Wider G., Wthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 2000, 97(1):145-150.
133. Zhang J. Studies on the structural stability of rabbit prion protein probed by molecular dynamics simulations of its wild-type and mutants. J. Theor. Biol. 2010, 264:119-122.
134. Zhang J. The structural stability of wild-type horse prion protein. J. Biomol. Struct. Dyn. 2011, 29(2):369-377.
135. Zhang J. Comparison studies of the structural stability of rabbit prion protein with human and mouse prion proteins. J. Theor. Biol. 2011, 269:88-95.
136. Zhang J. The nature of the infectious agents. PrP models of resistant species to prion diseases (dog, rabbit and horses). Prions and Prion Diseases. New Developments 2012, 41-48. NOVA Science Publishers, New York, (Chapter 2) ISBN 978-1-61942-768-6. J.M. Verdier (Ed.).
137. Zhang J., Liu D.D.W. Molecular dynamics studies on the structural stability of wild-type dog prion protein. J. Biomol. Struct. Dyn. 2011, 28(6):861-869.
138. Zhao X., Dong X., Zhou W. [Preparation of polyclonal antibody to human prion protein using the expressed GST-PrP fusion protein as antigen]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2000, 14(2):131-133.
139. Zhou G.P. Biological functions of soliton and extra electron motion in DNA structure. Phys. Scr. 1989, 40:698-701.
140. Zhou G.P. The disposition of the LZCC protein residues in Wenxiang diagram provides new insights into the protein-protein interaction mechanism. J. Theor. Biol. 2011, 284:142-148.
141. Zhou G.P. The structural determinations of the leucine zipper coiled-coil domains of the cGMP-dependent protein kinase I alpha and its interaction with the myosin binding subunit of the myosin light chains phosphase. Proteins Pept. Lett. 2011, 18:966-978.
142. PrPSc. Curr. Top. Med. Chem. 2013, 13(10):1152-1163.
143. Zhou Z., Yan X., Pan K., Chen J., Xie Z.S., Xiao G.F., Yang F.Q., Liang Y. Fibril formation of the rabbit/human/bovine prion proteins. Biophys. J. 2011, 101(6):1483-1492.
144. PrPC) and superoxide dismutase (SOD) in vascular cells under oxidative stress. Exp. Toxicol. Pathol. 2011, 63(3):229-236.